- Home
- CMPX vs FNKO Comparison
CMPX vs FNKO Comparison
Compare CMPX & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMPX
- FNKO
- Stock Information
- Founded
- CMPX 2014
- FNKO 2017
- Country
- CMPX United States
- FNKO United States
- Employees
- CMPX 35
- FNKO N/A
- Industry
- CMPX Biotechnology: Pharmaceutical Preparations
- FNKO Recreational Games/Products/Toys
- Sector
- CMPX Health Care
- FNKO Consumer Discretionary
- Exchange
- CMPX Nasdaq
- FNKO Nasdaq
- Market Cap
- CMPX 291.8M
- FNKO 215.5M
- IPO Year
- CMPX N/A
- FNKO 2017
- Fundamental
- Price
- CMPX $2.11
- FNKO $4.13
- Analyst Decision
- CMPX Strong Buy
- FNKO Buy
- Analyst Count
- CMPX 8
- FNKO 4
- Target Price
- CMPX $13.13
- FNKO $9.88
- AVG Volume (30 Days)
- CMPX 804.2K
- FNKO 1.5M
- Earning Date
- CMPX 05-08-2025
- FNKO 05-08-2025
- Dividend Yield
- CMPX N/A
- FNKO N/A
- EPS Growth
- CMPX N/A
- FNKO N/A
- EPS
- CMPX N/A
- FNKO N/A
- Revenue
- CMPX $850,000.00
- FNKO $1,024,890,000.00
- Revenue This Year
- CMPX N/A
- FNKO N/A
- Revenue Next Year
- CMPX N/A
- FNKO $8.02
- P/E Ratio
- CMPX N/A
- FNKO N/A
- Revenue Growth
- CMPX N/A
- FNKO N/A
- 52 Week Low
- CMPX $0.77
- FNKO $3.50
- 52 Week High
- CMPX $4.08
- FNKO $14.65
- Technical
- Relative Strength Index (RSI)
- CMPX 57.65
- FNKO 46.50
- Support Level
- CMPX $2.06
- FNKO $3.86
- Resistance Level
- CMPX $2.23
- FNKO $4.39
- Average True Range (ATR)
- CMPX 0.12
- FNKO 0.39
- MACD
- CMPX 0.01
- FNKO 0.08
- Stochastic Oscillator
- CMPX 69.23
- FNKO 28.39
About CMPX Compass Therapeutics Inc.
Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics to engage the immune system to treat solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to drug the immune system and identify optimal combinations empirically broadly. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of the following product candidates; CTX-009, CTX-471, CTX-10726, VEGF-IO Bispecific, and CTX-8371.
About FNKO Funko Inc.
Funko Inc is an us-based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.